Enel Health®Atlas
Sign in
Enel Health®Atlas
Browse libraries

Not medical advice. The Atlas is not a substitute for a clinician who can examine you.

Lipotropic / MIC

Methionine-Inositol-Choline Injectable

Evidence grade 1 of 5, Untested. Read how the Atlas grades evidence.

The full MIC / Lipo-C injectable (methionine, inositol, choline, usually with vitamin B12) has never been shown to cause fat loss in a controlled human trial, and the FDA states it is not aware of any credible scientific evidence that injected fat-dissolving compounds work for fat elimination. Isolated components carry only modest, non-injectable, non-weight-loss signals (oral myo-inositol lowers BMI by about 0.41 kg/m2 mainly in PCOS, choline prevents fatty liver at dietary intakes, B12 relieves fatigue only in documented deficiency), so the marketed weight-loss claim is effectively refuted while a bare metabolic-support signal remains anecdotal. Graded 1 (refuted for weight loss; components animal/observational at best).

FDA
Unapproved compounded product; no FDA-approved MIC/lipotropic injection and FDA states no credible evidence that injected fat-dissolving compounds work for fat elimination
WADA
Not prohibited

Reference only. Not medical advice.

What can go wrong

Not a peptide and not FDA approved; no controlled evidence of fat loss, composition varies by compounder, and injected fat-loss compounds carry FDA-reported harms in the related lipodissolve class.

Talk to a clinician before taking this. The Atlas can tell you what has been studied about Lipotropic / MIC. It cannot tell you how it would interact with your body, your history, or anything else you are taking, and nothing on this page is a reason to start.

Not a true peptide but a staple of weight-loss clinics, a compounded blend of methionine, inositol, and choline (often with B12) marketed to support fat metabolism. Grouped with injectable wellness compounds. Minimal controlled evidence.

What people take it for

These are the reasons people give for taking it. They are not effects it has been shown to have.

  • Fat-metabolism support (clinic use)
  • Weight-loss adjunct

How it is supposed to work

The honest starting point for Lipo-C is that it is not a peptide. It is a compounded injection of nutrients and an amino acid, methionine, inositol and choline, usually with vitamin B12, included here because it is sold alongside metabolic peptides in weight-loss clinics as a fat-burning shot. The idea is that these lipotropic, or fat-metabolizing, nutrients help the liver process fat and that B12 supports energy.

Lipo-C, also sold as a MIC or lipotropic injection, is not a peptide but a blend of methionine, an essential amino acid, inositol, a B-vitamin-like compound, and choline, an essential nutrient, usually combined with vitamin B12. The components are nutrients and amino-acid derivatives, not a peptide therapeutic.

Type
Nutrient blend, NOT a peptide
Contains
Methionine, inositol, choline, B12
Concept
Lipotropic, fat-metabolizing
Weight-loss evidence
Limited
Approval
None for weight loss
Role
Adjunct

Not A Peptide, And More A Nutrient Shot Than A Fat-Loss Drug

Lipo-C is one of the most familiar weight-loss-clinic offerings, and the honest framing is that it is real biochemistry doing modest work, not a peptide and not a powerful fat-loss drug. Each component genuinely participates in fat metabolism: methionine helps the liver process fats and feeds glutathione production, inositol is involved in fat metabolism and insulin signaling, choline supports liver function and fat transport, and B12 corrects a deficiency that is itself associated with higher body weight. The trouble is the leap from those real roles to meaningful weight loss. The published controlled-trial evidence for the injected blend is limited and lower quality than the evidence for the modern weight-loss medications, and much of the supporting science is for the individual ingredients, often taken orally and often in specific groups like women with polycystic ovary syndrome, rather than for the shot as a fat-loss treatment. It is not approved for weight loss. Candid clinicians position it as an adjunct to a supervised diet-and-exercise program, not a primary therapy and not a substitute for the far better-evidenced incretin drugs, with any energy boost largely a nutrient-correction effect that matters most in people who are actually deficient. It is generally low risk, being mostly vitamins and nutrients.

Safety in detail

Marketed weight-loss benefit is essentially refuted; any component-level signal is modest, oral, and outside weight loss. B12 helps only documented deficiency and choline/inositol act on liver and metabolic markers, not injectable fat burning.

  • It is not a peptide; it is a compounded nutrient and amino-acid injection.
  • It is generally low risk, being mostly vitamins and nutrients.
  • Weight-loss evidence is limited and lower quality than for the incretin drugs.
  • Any energy boost is largely a nutrient-correction effect in deficient people.

Children and teenagers

Lipo-C has no established pediatric weight-loss use and is not recommended in pregnancy or breastfeeding due to insufficient safety data for the injectable blend; it is not appropriate for minors.

What people get wrong

Nothing recorded here yet. There is almost certainly something people get wrong about this one, and the blank space means we have not written it down, not that the record is clean.

Who profits, and who pushes back

Nobody is named here yet, because we have not done that work on this entry. Read that as unfinished. Somebody almost certainly sells this, and somebody almost certainly disputes it. Assume both until we have checked.

Lipo-C is a decades-old cash-pay staple of medical spas and weight-loss clinics, sold as an inexpensive fat-burning shot and energy booster, and also available through gray-market and compounding channels. Its economy is volume add-on revenue rather than a defined pharmaceutical.

How we got here

Lipo-C is not a single drug and not a peptide but a clinic-compounded cocktail whose core is methionine, inositol, and choline, three lipotropic nutrients long claimed to help the liver mobilize fat. The idea traces to mid-20th-century observations that choline and methionine deficiency causes fatty liver in animals, which weight-loss clinics reframed as a fat-burning injection. It spread through medspas and telehealth weight-loss brands as MIC, then as MIC B12 and proprietary Lipo-C / Lipo-B labels that vary pharmacy to pharmacy, and it is frequently bundled today as an add-on to prescription GLP-1 programs. Regulators fold it into the broader family of unapproved injected fat-loss procedures (lipodissolve, mesotherapy, injection lipolysis) that the FDA warned about, distinct from deoxycholic acid / Kybella, the one injectable the FDA did approve and only for submental fat.

Lipotropic injections of methionine, inositol and choline have been a fixture of medical spas and weight-loss clinics for decades, marketed as fat-burning shots and frequently paired with vitamin B12. They predate and now sit alongside the modern metabolic peptides, sharing their channels while remaining a nutrient blend rather than a peptide.

The numbers behind the grade

Type
Nutrient blend
Not
A peptide
Contains
MIC plus B12
Concept
Lipotropic
Weight evidence
Limited
Role
Adjunct

The people taking it

A compounded nutrient-and-amino-acid injection, not a peptide, sold in weight-loss clinics as a fat-burning shot, with real component biochemistry but limited weight-loss evidence, best seen as an adjunct.

Lipo-C’s users are weight-loss-clinic and medical-spa clients seeking an affordable metabolism-and-energy boost, often as an add-on to a broader program, plus people with B12 deficiency who feel a genuine energy benefit.

A lipotropic nutrient injection sold in weight-loss clinics as a fat-burning and energy shot, not a peptide, with real component biochemistry but limited controlled weight-loss evidence and no approval.

Set against the alternatives

Lipo-C is grouped with the fat-loss peptides it is sold beside, AOD-9604 and the metabolic compound 5-Amino-1MQ, and its methionine content links it to the amino-acid antioxidant injection Glutathione, but it is a nutrient blend, not a peptide. Against the proven obesity medications like Semaglutide it is a far weaker, adjunct-level option. Its distinction is being the most nutrient-based and lowest-risk entry, with correspondingly modest expectations.

What we do not know

  • Whether the injected blend outperforms oral nutrients or placebo for weight loss.
  • Whether benefits extend beyond correcting an underlying deficiency.
  • Why an unproven shot persists alongside far better-evidenced weight drugs.

The market for this

What follows describes how this is bought and sold. It is not a buying guide and it is not an endorsement of any seller.

Lipo-C is a familiar, low-risk, nutrient-based shot, but it is not a peptide and the evidence that injecting it produces meaningful weight loss is limited, with much of the supporting science being for the individual ingredients taken orally or in specific groups. Anyone considering it should treat it as a supportive adjunct to diet and exercise rather than a fat-loss treatment, expect any energy benefit to matter most if genuinely B12-deficient, and recognize it is no substitute for the far better-evidenced weight-loss medications.

Compounded through wellness clinics and pharmacies; formulations vary.

What this entry does not yet cover

What follows is unfinished work on our side, not a finding about Lipotropic / MIC.

  • Timeline. We have not built the dated record of research and regulatory events.
  • Supply chain. We have not mapped where it is made.
  • What could change. No forward-looking summary yet.

Sources

The studies that matter

  • Not a peptidefact

    Lipo-C is a compounded blend of nutrients and an amino acid, sold alongside peptides but not a peptide.

  • Real component biologyestablished

    Methionine, inositol and choline all genuinely participate in fat metabolism and liver function.

  • Weight-loss evidencelimited

    Controlled-trial evidence for the injected blend is limited; much support is for individual ingredients, often oral.

  • Positioninghonest

    Not approved for weight loss; best framed as an adjunct to diet and exercise, not a primary therapy.